These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9131950)

  • 1. Under-reporting of adverse drug reactions in general practice.
    Moride Y; Haramburu F; Requejo AA; Bégaud B
    Br J Clin Pharmacol; 1997 Feb; 43(2):177-81. PubMed ID: 9131950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.
    Alvarez-Requejo A; Carvajal A; Bégaud B; Moride Y; Vega T; Arias LH
    Eur J Clin Pharmacol; 1998 Aug; 54(6):483-8. PubMed ID: 9776440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
    Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
    Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Completeness of pharmacovigilance reporting in general medicine in France.].
    Humbert X; Jacquot J; Alexandre J; Sassier M; Robin N; Pageot C; Kheloufi F; Joyau C; Coquerel A; Durrieu G; Fedrizzi S
    Sante Publique; 2019; Vol. 31(4):561-566. PubMed ID: 31959257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).
    Biagi C; Montanaro N; Buccellato E; Roberto G; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2013 Feb; 69(2):237-44. PubMed ID: 22706618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.
    Ranganathan SS; Houghton JE; Davies DP; Routledge PA
    Br J Clin Pharmacol; 2003 Dec; 56(6):658-63. PubMed ID: 14616426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region].
    Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc JL
    Therapie; 1995; 50(5):459-62. PubMed ID: 8571286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?
    Bäckström M; Mjörndal T
    Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.
    Gerritsen R; Faddegon H; Dijkers F; van Grootheest K; van Puijenbroek E
    Drug Saf; 2011 Sep; 34(9):755-62. PubMed ID: 21830837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
    Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
    JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underreporting of adverse drug reactions: attitudes of Irish doctors.
    Williams D; Feely J
    Ir J Med Sci; 1999; 168(4):257-61. PubMed ID: 10624366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.